Cytokine profiles in HPV-associated cervical intraepithelial neoplasia.

A Aleksandra Nikolaevna Riger (Moscow Research Institute of Oncology Named After P. A. Herzen, Moscow) N Nataliy Kharchenko (Peoples' Friendship University of Russia, Moscow, Russian Federation) I Irina Antonova (Russian Scientific Center of Roentgen Radiology (RSCRR), Moscow, Russian Federation) E Evgenia Khatkova (Moscow Clinical Scientific Center Named After A.S. Loginov, Moscow, Russian Federation) A Attila Major (Femina Gynecology Center, Geneva, Switzerland) V Vasilii Khammad (James Cancer Hospital and Solove Research Institute, Columbus, OH) M Maxim Nesterov (Sacramento State University, Sacramento, CA) A Andrey Kaprin (1P.A. Hertsen Moscow Oncology Research Institute, branch of the National Medical Radiology Research Center, Moscow, Russian Federation)

Abstract

e22517 Background: Persistent high-risk human papillomavirus (HPV) infection is a well-established driver of cervical intraepithelial neoplasia (CIN), yet progression risk varies among patients. Cytokines shape antiviral immunity and tissue remodeling, and cytokine profiling is emerging as a cost-effective tool to stratify CIN risk and refine prognostic assessment in this population. Objective: Our study evaluated serum and cervical mucus cytokine profiles in HPV-negative normal cytology and in low-grade squamous intraepithelial lesion (LSIL) and high-grade squamous intraepithelial lesion (HSIL), stratified by HPV genotype and viral load. Methods: Ninety women aged 18–80 years were enrolled, including 30 healthy controls and 60 HPV-positive patients with histologically confirmed CIN (LSIL, n = 30; HSIL, n = 30). Levels of 27 cytokines (pg/mL), including FGF, GM-CSF, IFN-γ, IL-1β, IL-2, IL-4, IL-6, IL-8, IL-10, IL-12p70, IL-17A, TNF-α, VEGF, and selected chemokines, were measured in serum and cervical mucus using the Bio-Plex Pro Human Cytokine 27-plex assay (Bio-Rad, USA) on a Luminex 200 platform. The IL-10/IL-17A ratio was calculated. Cytokine profiles were stratified by HPV genotype [HPV(−), HPV(+) 16/18, HPV(+) 31–73] and viral load [HPV(−), low ( < 5), high (≥5)]. Data were reported as median (Q1–Q3). Statistical analyses included one-way ANOVA with pairwise t-tests and Bonferroni correction; p < 0.05 was considered significant. Results: Serum: LSIL was characterized by increased GM-CSF, IL-4, IL-7, and IL-8 with decreased IL-2, IL-5, IL-17A, and angiogenic factors (FGF/VEGF); the IL-10/IL-17A ratio was reduced (p < 0.05). HSIL showed increased IL-7, IL-10, TNF-α, IL-8, MCP-1, and FGF with decreased IL-2, IL-5, and IL-17A; the IL-10/IL-17A ratio was increased (p < 0.05). Cervical mucus: LSIL demonstrated increased IL-10, IL-1β/IL-1ra, IL-2, IL-4, TNF-α, and FGF with reduced IL-8 and IP-10. HSIL showed broader immune activation with increased IL-10, IL-12p70, IL-17A, IL-1β, IL-6, TNF-α, GM-CSF, FGF, and VEGF, alongside decreased IL-9, IL-8, and IP-10 (p < 0.05). Conclusions: CIN grade was associated with distinct systemic and local cytokine signatures, with HSIL showing broader proinflammatory activation in cervical mucus and a grade-dependent shift in the serum IL-10/IL-17A ratio, consistent with compartmentalized immune dysregulation in HPV-associated disease.

Article Details

Volume / Issue Vol. 44, Issue 16_suppl
Published June 01, 2026
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins

ISSN: 0732-183X Health Sciences

Authors (8)

A

Aleksandra Nikolaevna Riger

Moscow Research Institute of Oncology Named After P. A. Herzen, Moscow

N

Nataliy Kharchenko

Peoples' Friendship University of Russia, Moscow, Russian Federation

I

Irina Antonova

Russian Scientific Center of Roentgen Radiology (RSCRR), Moscow, Russian Federation

E

Evgenia Khatkova

Moscow Clinical Scientific Center Named After A.S. Loginov, Moscow, Russian Federation

A

Attila Major

Femina Gynecology Center, Geneva, Switzerland

V

Vasilii Khammad

James Cancer Hospital and Solove Research Institute, Columbus, OH

M

Maxim Nesterov

Sacramento State University, Sacramento, CA

A

Andrey Kaprin

1P.A. Hertsen Moscow Oncology Research Institute, branch of the National Medical Radiology Research Center, Moscow, Russian Federation